OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment of Liver Hydatid Disease with Mebendazole: A Prospective Study of Thirteen Cases.
Published in:
American Journal of Gastroenterology (Springer Nature), 1983, v. 78, n. 9, p. 584
By:
- Gil-Grande, L. A.;
- Boixeda, D.;
- Garcia-Hoz, F.;
- Barcena, R.;
- Lledo, A.;
- Suarez, E.;
- Pascasio, J. M.;
- Moreira, V.
Publication type:
Article
Solitary ileocolic arteriovenous malformation: spongostan and silk therapeutic embolisation.
Published in:
1997
By:
- Alcalde, M.;
- Jiménez, G.;
- Díaz, P.;
- García-Díaz, M.;
- Pascasio, J. M.;
- Moro, R.;
- Zapata, J.;
- López-Santamaría, A.
Publication type:
journal article
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 4, p. 304, doi. 10.1111/jvh.12648
By:
- Alonso, S.;
- Riveiro‐Barciela, M.;
- Fernandez, I.;
- Rincón, D.;
- Real, Y.;
- Llerena, S.;
- Gea, F.;
- Olveira, A.;
- Fernandez‐Carrillo, C.;
- Polo, B.;
- Carrión, J. A.;
- Gómez, A.;
- Devesa, M. J.;
- Baliellas, C.;
- Castro, Á.;
- Ampuero, J.;
- Granados, R.;
- Pascasio, J. M.;
- Rubín, A.;
- Salmeron, J.
Publication type:
Article
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study ( PLUTO).
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 3, p. 468, doi. 10.1111/apt.13883
By:
- Buti, M.;
- Calleja, J. L.;
- Lens, S.;
- Diago, M.;
- Ortega, E.;
- Crespo, J.;
- Planas, R.;
- Romero‐Gómez, M.;
- Rodríguez, F. G.;
- Pascasio, J. M.;
- Fevery, B.;
- Kurland, D.;
- Corbett, C.;
- Kalmeijer, R.;
- Jessner, W.
Publication type:
Article
Undetectable HCV- RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 5, p. 469, doi. 10.1111/jvh.12342
By:
- Bruno, S.;
- Bollani, S.;
- Zignego, A. L.;
- Pascasio, J. M.;
- Magni, C.;
- Ciancio, A.;
- Caremani, M.;
- Mangia, A.;
- Marenco, S.;
- Piovesan, S.;
- Chemello, L.;
- Babudieri, S.;
- Moretti, A.;
- Gea, F.;
- Colletta, C.;
- Perez‐Alvarez, R.;
- Forns, X.;
- Larrubia, J. R.;
- Arenas, J.;
- Crespo, J.
Publication type:
Article

Found: 5

Treatment of Liver Hydatid Disease with Mebendazole: A Prospective Study of Thirteen Cases.

Solitary ileocolic arteriovenous malformation: spongostan and silk therapeutic embolisation.

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study ( PLUTO).

Undetectable HCV- RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.